Skip to main content

Month: June 2025

CarMax Announces Tools, Resources and Incentives to Enhance Used EV Buying Experience

Battery health data through Recurrent and $200 home charging installation credit from Treehouse empowers used EV car shoppersCarMax Announces Tools, Resources and Incentives to Enhance Used EV Buying ExperienceCarMax Announces Tools, Resources and Incentives to Enhance Used EV Buying ExperienceCarMax Announces Tools, Resources and Incentives to Enhance Used EV Buying ExperienceCarMax Announces Tools, Resources and Incentives to Enhance Used EV Buying ExperienceRichmond, VA, June 04, 2025 (GLOBE NEWSWIRE) — CarMax, Inc. (NYSE: KMX), the nation’s largest retailer of used cars, today announced a series of strategic initiatives designed to enhance the used electric vehicle (EV) buying experience for consumers. CarMax is partnering with innovative companies to introduce an advanced battery health assessment tool and...

Continue reading

Yes& Supercharges Creative Capabilities with Acquisition of Hothouse

Latest Move Strengthens Agency’s National Growth Washington, DC, June 04, 2025 (GLOBE NEWSWIRE) — Yes&, the premier, independent, fully-integrated creative agency based in greater Washington, DC, with remote staff in 32 states and three countries, today announced its acquisition of Atlanta-based creative agency Hothouse. This move marks the latest milestone in Yes&’s strategic expansion and national growth strategy. The addition of Hothouse bolsters the ongoing efforts of Yes& to enhance its creative offerings for world-class brands, expand its footprint into new markets, and diversify its expertise in key sectors. Hothouse is renowned for its outstanding creative and production portfolio and experience in market sectors such as entertainment, hospitality, automotive, and sports. The move also gives Yes& a dynamic...

Continue reading

Treasure Global Launches US$100 Million Digital Asset Treasury Strategy to Power Next-Gen Consumer Intelligence Platform

Capital Strategy Designed to Strengthen Digital Infrastructure, Enhance Treasury Efficiency, and Accelerate Rollout of Real-Time Data-Driven Retail Platform KUALA LUMPUR, Malaysia, June 04, 2025 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a leading e-commerce platform operator, today announced the launch of a US$100 million digital asset treasury initiative as a part of a broader strategy to reinforce its digital infrastructure and support the forthcoming launch of its AI-powered consumer intelligence platform in the third quarter of 2025. The treasury initiative is backed by two capital sources:US$50 million from an existing equity financing agreement. US$50 million secured through a new institutional commitment from a strategic funding partner.The strategy enables Treasure Global...

Continue reading

60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format

New 8-count bottles now available through major retail pharmacies ARAKODA® is the only weekly prophylactic therapy to provide protection against the blood and liver stages of malariaWASHINGTON, June 04, 2025 (GLOBE NEWSWIRE) —  60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the introduction of a new 8-count bottle format for ARAKODA® (tafenoquine). The 8-count bottle format may be suitable for use with patients who are making shorter trips to areas of the world where malaria is endemic. The new format expands the packaging options available to healthcare professionals who prescribe ARAKODA for the prevention of malaria and travelers taking trips of one week or less. The 8-count bottles...

Continue reading

Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107)

Annamycin delivering better performance 7th line than would be expected even in 2nd line for monotherapy Responders (Stable Disease or Partial Response) after 2 cycles of Annamycin showed improvement in OS and Progression Free Survival (“PFS”) Clinical Benefit Rate (“CBR”) was 59.4% (n=32), comprised of 18 subjects with stable disease and 1 subject with a partial response Potential to address 13,500 new incidents of STS each year and market opportunity expected to grow to $2.6B by 20301 On-demand video webcast with members of the Moleculin management team and internationally renowned Key Opinion Leaders available Thursday, June 5th HOUSTON, June 04, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting...

Continue reading

Synergy CHC Announces New $20 Million Long-Term Credit Facility

WESTBROOK, Maine, June 04, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it has entered into a $20 million term loan credit agreement, due May 2029 with ACP Agency, LLC. The proceeds will be used to pay down debt and provide the Company with growth capital. Under the terms of the agreement, the Company received a $15 million term loan at closing, with an interest rate of SOFR plus 8.5%. The loan is interest-only through 2025, with quarterly principal payments of $175,000 beginning in January 2026, increasing to $350,000 per quarter in 2027 and beyond. A $2.5 million delayed draw facility and $2.5 million uncommitted term loan incremental facility are also available to the Company. “We are very pleased to have...

Continue reading

BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor

Los Angeles, CA and Vancouver, BC, June 04, 2025 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“Streamex”) in May 2025, is pleased to announce the appointment of Sean Roosen as Strategic Advisor to Streamex. Mr. Roosen, a globally recognized mining entrepreneur and financier, brings over three decades of experience in building and scaling multibillion-dollar resource ventures. Mr. Roosen is the Founder, Executive Chairman, and Chief Executive Officer of Osisko Development Corp., a premier North American gold development company. He is also the founder and former Executive Chairman and CEO of Osisko Gold Royalties, where he served from its inception in 2014 until 2023. A founding member of Osisko Mining Corporation (2003)...

Continue reading

Asia Broadband Approves Shareholder Stock Dividend

LAS VEGAS, June 04, 2025 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) announced today that the Company’s management and Board of Directors have approved a new stock dividend. The common share dividend will be distributed on the basis of 1 dividend share for every 35 shares owned representing over 100 million restricted shares to be distributed. AABB management is currently finalizing the imminent dividend record date and the distribution details with its transfer agent. Further details of the dividend will be announced next week. Additionally, the Company has confirmed with its transfer agent that all past dividend shares submitted will be released immediately of any restrictions. AABB continues to advance the corporate initiative to reward its loyal shareholder base for their continued support and...

Continue reading

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

HCW Biologics earned upfront payment and will recognize revenue of $7.0 million in Q2 2025 MIRAMAR, Fla., June 04, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, announced today that WY Biotech has completed its due diligence related to HCWB’s technology transfer report, including the characterization of the cell line, delivered on May 13, 2025. In addition, WY Biotech confirmed its commitment to proceed with the development and commercialization...

Continue reading

Results of Venetus’ proposed placing of shares in Theon International to strengthen the free float and liquidity of the stock

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)4 June 2025 – Theon International Plc (“Theon” or the “Company”) has been informed that its shareholder Venetus Limited (“Venetus”) (whose shares are primarily held by key executives of Theon Group and Theon CEO, Christianos Hadjiminas), has successfully completed the sale of approximately 3.73 million shares in Theon equal to approximately 5.3% of the share capital of the Company (the “Placing”). The final deal was upsized from initial indications. The Company will not receive any proceeds from the Placing. Venetus’ aim is to increase the free float of the Company and subsequently improve liquidity of Theon shares. In connection with the transaction, Berenberg and UBS Europe SE acted as Joint Global Coordinators and Joint Bookrunners, while WOOD & Company Financial Services...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.